why choose us

First received: January 09, 2026

Clinical Trial: Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Telogen Effluvium

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Millet Seed Extract in the Treatment of Telogen Effluvium in Female Patients: A Randomized, Double-Blind, Controlled Trial

Brief Summary: This is a randomized, double-blind, controlled clinical trial investigating the efficacy and safety of millet seed extract capsules in treating telogen effluvium in female patients.The study will recruit 60 female participants with telogen effluvium who will be randomly assigned to receive either millet seed extract capsules (containing 420 mg millet seed extract, 200 mcg biotin, 6 mg L-cystine, and 27.48 mg vitamin B5) twice daily or Biotin forte capsules (5 mg biotin) once daily for 12 weeks.The primary outcome…

Read more